Skip to content
JournalsWorldThe Global Research Discovery Platform
Login Sign Up

Academic Journal

Q2

Frontiers in Antibiotics

Frontiers Media SA

SwitzerlandDrug Discovery (Q2); Infectious Diseases (Q2); Microbiology (medical) (Q2); Pharmacology (Q2)ISSN-matched source record
Submission information ↗
Q2Ranking
—Impact Factor (year unverified)
11H-index (SCImago 2025)
0.854SJR (2025)
2022-2026Coverage

About Frontiers in Antibiotics

Frontiers in Antibiotics is a scholarly journal published by Frontiers Media SA. SCImago 2025 lists it in Q2, with an SJR of 0.854 and H-index of 11.

Coverage: 2022-2026. Research categories: Drug Discovery (Q2); Infectious Diseases (Q2); Microbiology (medical) (Q2); Pharmacology (Q2).

Open-access policies and author information

Reported in the official DOAJ public CSV snapshot (2026-09-01), downloaded 2026-10-03. Record updated 2026-03-12. This snapshot does not establish today’s listing status or fee quotation.

Accepted manuscript languagesEnglish
Licence optionsCC BY
Peer-review processAnonymous peer review
APCDOAJ-reported APC: 1950 CHF
Waiver policy reportedYes
Other fees reportedNo
Author retains unrestricted copyrightYes
Digital preservationCLOCKSS, PMC
Reported submission-to-publication time15 weeks on average; not a guarantee
Openly licensed content since2022 (not the journal founding year)

Publisher policy links recorded by DOAJ

Source: DOAJ journal record. Journal metadata is distributed by DOAJ under CC0. Confirm current fees, tax, eligibility and waiver terms with the publisher.

Source-backed journal facts

ISSN(s)2813-2467
ISSN-L2813-2467
Source typeJournal
Publisher / hosting organisationFrontiers Media
Fully open access (OpenAlex)Yes
DOAJ flag (OpenAlex)Listed in OpenAlex metadata; confirm current status in DOAJ
Works recorded in OpenAlex138
Citations recorded in OpenAlex885
OpenAlex H-index15
Years represented in OpenAlex2022–2026 (not the founding or closing dates)

Topics in published research

Antibiotic Resistance in Bacteria; Antibiotic Use and Resistance; Pharmaceutical and Antibiotic Environmental Impacts; Antibiotics Pharmacokinetics and Efficacy; Bacterial Identification and Susceptibility Testing; Tuberculosis Research and Epidemiology.

OpenAlex classifies topics from published works. These topics are not the publisher’s official aims and scope.

Source: OpenAlex source record. Retrieved 2026-10-03. Source record updated 2026-10-02. OpenAlex metrics are different from SCImago metrics and the Clarivate Journal Impact Factor.

Found incorrect or outdated information?Help us keep this profile accurate.
Suggest an Edit